0001140361-15-002749.txt : 20150126 0001140361-15-002749.hdr.sgml : 20150126 20150126170554 ACCESSION NUMBER: 0001140361-15-002749 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20150126 DATE AS OF CHANGE: 20150126 EFFECTIVENESS DATE: 20150126 FILER: COMPANY DATA: COMPANY CONFORMED NAME: AntriaBio, Inc. CENTRAL INDEX KEY: 0001509261 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 273440894 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-232884 FILM NUMBER: 15549240 BUSINESS ADDRESS: STREET 1: 1450 INFINITE DRIVE CITY: LOUISVILLE STATE: CO ZIP: 80027 BUSINESS PHONE: 650-847-1919 MAIL ADDRESS: STREET 1: 1450 INFINITE DRIVE CITY: LOUISVILLE STATE: CO ZIP: 80027 FORMER COMPANY: FORMER CONFORMED NAME: FITS MY STYLE INC DATE OF NAME CHANGE: 20110104 D 1 primary_doc.xml X0707 D LIVE 0001509261 AntriaBio, Inc. 1450 Infinite Drive Louisville CO COLORADO 80027 650-847-1919 DELAWARE FITS MY STYLE INC. FITS MY STYLE INC Corporation true 2010 Nevan Charles Elam 1450 Infinite Drive Louisville CO COLORADO 80027 Executive Officer Director Hoyoung Huh 1450 Infinite Drive Louisville CO COLORADO 80027 Director Executive Officer Sankaram Mantripragada 1450 Infinite Drive Louisville CO COLORADO 80027 Executive Officer Morgan Lynn Fields 1450 Infinite Drive Louisville CO COLORADO 80027 Executive Officer Barry Sherman 1450 Infinite Drive Louisville CO COLORADO 80027 Director Biotechnology Decline to Disclose 06b false 2014-11-28 false true true true true Unit = 1 common share and 1 common share purchase warrant. false 0 Paulson Investment Company, Inc. 5670 None None 1331 NW Lovejoy Portland OR OREGON 97209 CA CALIFORNIA CT CONNECTICUT FL FLORIDA GA GEORGIA IL ILLINOIS MI MICHIGAN MN MINNESOTA NJ NEW JERSEY NY NEW YORK PA PENNSYLVANIA TX TEXAS WA WASHINGTON MA MASSACHUSETTS NV NEVADA WI WISCONSIN OH OHIO false 35270270 6925580 28344690 Aggregate offering includes amount that may be received by Issuer upon exercise of warrants. Each warrant may be exercised for 1 common share at a price of $2.50 per share for a period of 36 months from date of issuance. false 73 692558 0 In addition to cash, the agent may receive up to 484,791 warrants. Each warrant may be exercised for 1 common share at a price of $2.50 per share for a period of 36 months from date of issuance. 0 false AntriaBio, Inc. /s/ Morgan Lynn Fields Morgan Lynn Fields Chief Accounting Officer 2014-01-22